Sandbox:MGS: Difference between revisions
Jump to navigation
Jump to search
| Line 3: | Line 3: | ||
{{CMG}}{{AE}} {{MGS}} | {{CMG}}{{AE}} {{MGS}} | ||
== | {| style="border: 0px; font-size: 90%; margin: 3px; width: 800px" | ||
|valign=top| | |||
|+ | |||
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Treatment regimen }} | |||
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|Side effects}} | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | | |||
'''CHOP-R regimen''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| Cyclophosphamide | |||
| Nausea | |||
|- | |||
| Doxorubicin | |||
| Alopecia | |||
|- | |||
| Vincristine | |||
| Granulocytopenia | |||
|- | |||
| Prednisone | |||
| | |||
|- | |||
| Rituximab | |||
| | |||
|- | |||
| | |||
| | |||
|- | |||
| Ibrutinib | |||
| Fatigue | |||
|- | |||
| | |||
| Cytopenia | |||
|- | |||
| | |||
| | |||
|- | |||
| Rituximab | |||
| Infusion related reaction | |||
|- | |||
| | |||
| Infections | |||
|- | |||
| | |||
| | |||
|- | |||
| FR regimen: | |||
| | |||
|- | |||
| Fludarabine | |||
| Neutropenia (63%) | |||
|- | |||
| Rituximab | |||
| Thrombocytopenia | |||
|- | |||
| | |||
| Pneumonia | |||
|- | |||
| | |||
| | |||
|- | |||
| BDR regimen: | |||
| | |||
|- | |||
| Bortezomib | |||
| Peripheral Neuropathy - reversible in 61% of patients | |||
|- | |||
| Dexamethasone | |||
| | |||
|- | |||
| Rituximab | |||
| | |||
|- | |||
| | |||
| | |||
|- | |||
| DRC regimen: | |||
| | |||
|- | |||
| Dexamethasone | |||
| Neutropenia | |||
|- | |||
| Rituximab | |||
| | |||
|- | |||
| Cyclophosphamide | |||
| | |||
|- | |||
| | |||
| | |||
|- | |||
| CR regimen: | |||
| | |||
|- | |||
| Cladribine | |||
| Anemia | |||
|- | |||
| Rituximan | |||
| Neurological Symptoms | |||
|- | |||
| | |||
| symptomatic cryoglobunemia | |||
|- | |||
| | |||
| Thrombocytopenia | |||
|} | |||
==References== | ==References== | ||
Revision as of 16:28, 17 November 2015
|
Waldenström's macroglobulinemia Microchapters |
|
Differentiating Waldenström's macroglobulinemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Sandbox:MGS On the Web |
|
American Roentgen Ray Society Images of Sandbox:MGS |
|
Directions to Hospitals Treating Waldenström's macroglobulinemia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mirdula Sharma, MBBS [2]
| Treatment regimen | Side effects | ||
|---|---|---|---|
|
CHOP-R regimen |
Cyclophosphamide | Nausea | |
| Doxorubicin | Alopecia | ||
| Vincristine | Granulocytopenia | ||
| Prednisone | |||
| Rituximab | |||
| Ibrutinib | Fatigue | ||
| Cytopenia | |||
| Rituximab | Infusion related reaction | ||
| Infections | |||
| FR regimen: | |||
| Fludarabine | Neutropenia (63%) | ||
| Rituximab | Thrombocytopenia | ||
| Pneumonia | |||
| BDR regimen: | |||
| Bortezomib | Peripheral Neuropathy - reversible in 61% of patients | ||
| Dexamethasone | |||
| Rituximab | |||
| DRC regimen: | |||
| Dexamethasone | Neutropenia | ||
| Rituximab | |||
| Cyclophosphamide | |||
| CR regimen: | |||
| Cladribine | Anemia | ||
| Rituximan | Neurological Symptoms | ||
| symptomatic cryoglobunemia | |||
| Thrombocytopenia |